Aug 12, 2021
Featuring slide presentations and related discussion from Drs Michael J Birrer, Kathleen Moore and Richard T Penson, including the following topics:
Genetic Testing in Ovarian Cancer; Integration of PARP Inhibitor Maintenance into the Management of Newly Diagnosed Disease — Michael J Birrer, MD, PhD (0:00)
Selection and Sequencing of Therapy for Relapsed/Refractory Ovarian Cancer — Richard Penson, MD, MRCP (42:24)
Future Directions in Ovarian Cancer Treatment — Kathleen Moore, MD (1:18:27)